Update date
31 Mar 2026
Shareable Research Card
RXRX - RECURSION PHARMACEUTICALS, INC. Return On Invested Capital
This metric view shows RXRX - RECURSION PHARMACEUTICALS, INC. return on invested capital history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2026
- Latest reported value
- -54%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2026
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2026.
- Latest reported value on this page: -54%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Return On Invested Capital
Latest reported return on invested capital: -54%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 06 May 2026.
Benchmark Context
How Return On Invested Capital compares with peers
RECURSION PHARMACEUTICALS, INC. is outside the visible top 120 companies for return on invested capital in the current sample.
Compared with
Compared with 120 companies reporting return on invested capital in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -2.6x the current sample midpoint. Return On Invested Capital is up about 26% versus the comparable prior period.
- Visible rows currently span reported period ends from 02 Apr 2011 to 03 May 2026.
- Nearby companies in this sample: Inhibitor Therapeutics, Inc. and AMARIN CORP PLC\UK.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
RECURSION PHARMACEUTICALS, INC.: Return On Invested Capital
Latest period: Q1 2026. Period end: 31 Mar 2026. Units: %. Frequency: quarterly and annual.
Return on invested capital measures how efficiently a company generates operating profit from capital invested in the business. Calculated as net income over shareholder equity plus long-term debt.
Metric Snapshot
- Latest value
- -54%
- Coverage range
- 31 Mar 2025 - 31 Mar 2026
- Fact rows
- 6
What This Metric Tells You
- Shows reported return on invested capital over 31 Mar 2025 - 31 Mar 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 6 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Invested Capital levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Inhibitor Therapeutics, Inc. (inti) | 562% | Quarter - 31 Mar 2026 | Open Inhibitor Therapeutics, Inc. Return On Invested Capital |
| 2 | AMARIN CORP PLC\UK (amrn) | 543% | Quarter - 31 Mar 2012 | Open AMARIN CORP PLC\UK Return On Invested Capital |
| 3 | USBC, Inc. (usbc) | 393% | Year - 30 Sep 2019 | Open USBC, Inc. Return On Invested Capital |
| 4 | Vivid Seats Inc. (seat) | 377% | Year - 31 Dec 2025 | Open Vivid Seats Inc. Return On Invested Capital |
| 5 | Trutankless, Inc. | 351% | Quarter - 30 Sep 2021 | Open Trutankless, Inc. Return On Invested Capital |
| 6 | CPI AEROSTRUCTURES INC (cvu) | 297% | Quarter - 30 Jun 2023 | Open CPI AEROSTRUCTURES INC Return On Invested Capital |
Metric Details
- Metric
- Return On Invested Capital (ROIC)
- Frequency coverage
- quarterly and annual
- Taxonomy
- ratio
- Units tracked
- %
- History range
- 31 Mar 2025 - 31 Mar 2026
- Facts on this page
- 6
- Metric definition
- Return on invested capital measures how efficiently a company generates operating profit from capital invested in the business. Calculated as net income over shareholder equity plus long-term debt.
- SEC metric endpoint
- Open SEC company concept
Metric identity
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
SEC evidence
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Invested Capital, Quarterly (%)
Return On Invested Capital, YoY Quarterly Change (%)
Return On Invested Capital, Annual (%)
RECURSION PHARMACEUTICALS, INC. Quarterly Return On Invested Capital (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2026 | -54% | +19% | +26% | 01 Jan 2026 | 31 Mar 2026 |
| Q4 2025 | -63% | 01 Oct 2025 | 31 Dec 2025 | ||
| Q3 2025 | -72% | 01 Jul 2025 | 30 Sep 2025 | ||
| Q2 2025 | -75% | 01 Apr 2025 | 30 Jun 2025 | ||
| Q1 2025 | -73% | 01 Jan 2025 | 31 Mar 2025 |
RECURSION PHARMACEUTICALS, INC. Annual Return On Invested Capital (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -63% | 01 Jan 2025 | 31 Dec 2025 |
* marks a reported value that did not pass the local value check.